Pharmaceutical Commerce

AUGUST 11, 2022

Pharmaceutical distribution today is anything but monolithic. While companies in this space are grappling with issues ranging from inflation and supply chain disruption to workforce scarcity and DSCSA implementation, there’s still plenty of room for smaller players to stake out part of the terrain to call their own.

Distribution 116

Distribution Pharmaceutical Distribution Pharma Pharmaceutical 116

Pharmacy Times

MAY 17, 2024

Natalie Bedford, senior vice president, US Pharmaceutical Distribution Services at McKesson, discusses the unique challenges of distributing specialty drugs.

Distribution 26

Distribution Pharmaceutical Distribution Pharmaceutical 26

Celeritas

OCTOBER 14, 2022

Stakeholder Mapping involves identifying professionals in the target therapeutic field who would utilize or influence the utilization of the pharmaceutical product. Contacting stakeholders can be key to knowing where they stand upon the release of the pharmaceutical product. What is a Stakeholder Map? Step 1: Identify Key Stakeholders.

Pharmaceutical products 52

Pharmaceutical products Pharmaceutical Distribution Pharmaceutical Distribution 52

Pharmaceutical Technology

MAY 30, 2023

The Italian pharmaceutical company Abiogen Pharma completed an acquisition of a 97.09% stake in the Swiss orphan conditions-focused EffRx Pharmaceuticals on May 29. Altamedics specialises in pharmaceutical distribution in hospital settings.

Pharmaceutical Distribution 52

Pharmaceutical Distribution Distribution Medicine Pharmaceutical 52

Pharmaceutical Technology

SEPTEMBER 14, 2022

Pharmaceutical Technology has listed the leading API biologics (protein and peptide) companies in contract marketing based on its intel, insights, and decades-long experience in the sector. The post Leading API biologics (protein and peptide) companies in contract marketing appeared first on Pharmaceutical Technology.

Leads 52

Leads Marketing Pharmacology Retail 52

Celeritas

OCTOBER 23, 2022

An MSL is a medically specialized representative for pharmaceutical companies. Furthering the pharmaceutical company’s interests is not their primary responsibility; rather it is to promote their concepts and developments. It’s important to first identify all actors who will play a part in the pharmaceutical distribution process.

Medical science 40

Medical science Medical Specialization Doctors 40